CervoMed Inc. Net Income Loss

• CervoMed Inc. showed a decrease of -65.5% in Net Income Loss from 2024 to 2025.
• This data is from CervoMed Inc.'s annual report (Form 10-K), filed with the SEC on March 13, 2026.
• XBRL data for this metric is available from 2010 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 15 years of available data (2010 to 2025), CervoMed Inc.'s Net Income Loss has declined by 220.7%.
• Historical annual values: Fiscal year 2025: -$26.97 million | Fiscal year 2024: -$16.29 million | Fiscal year 2023: -$2.17 million | Fiscal year 2022: -$5.80 million | Fiscal year 2021: -$24.10 million | Fiscal year 2020: -$14.19 million | Fiscal year 2019: -$11.80 million | Fiscal year 2018: -$18.37 million | Fiscal year 2017: -$1.36 million | Fiscal year 2016: -$18.04 million | Fiscal year 2015: -$6.72 million | Fiscal year 2014: -$14.35 million | Fiscal year 2013: -$2.46 million | Fiscal year 2011: -$15.84 million | Fiscal year 2010: -$8.41 million.
• Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: June 20, 2026